JP2016539131A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539131A5
JP2016539131A5 JP2016535210A JP2016535210A JP2016539131A5 JP 2016539131 A5 JP2016539131 A5 JP 2016539131A5 JP 2016535210 A JP2016535210 A JP 2016535210A JP 2016535210 A JP2016535210 A JP 2016535210A JP 2016539131 A5 JP2016539131 A5 JP 2016539131A5
Authority
JP
Japan
Prior art keywords
salt
arachidylamide
cholan
dihydroxy
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016535210A
Other languages
English (en)
Japanese (ja)
Other versions
JP6675310B2 (ja
JP2016539131A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2014/051052 external-priority patent/WO2015083164A1/en
Publication of JP2016539131A publication Critical patent/JP2016539131A/ja
Publication of JP2016539131A5 publication Critical patent/JP2016539131A5/ja
Application granted granted Critical
Publication of JP6675310B2 publication Critical patent/JP6675310B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016535210A 2013-12-04 2014-12-04 アラムコール塩 Active JP6675310B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361911478P 2013-12-04 2013-12-04
US61/911,478 2013-12-04
PCT/IL2014/051052 WO2015083164A1 (en) 2013-12-04 2014-12-04 Aramchol salts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020040825A Division JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Publications (3)

Publication Number Publication Date
JP2016539131A JP2016539131A (ja) 2016-12-15
JP2016539131A5 true JP2016539131A5 (OSRAM) 2018-01-18
JP6675310B2 JP6675310B2 (ja) 2020-04-01

Family

ID=53272986

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016535210A Active JP6675310B2 (ja) 2013-12-04 2014-12-04 アラムコール塩
JP2020040825A Pending JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020040825A Pending JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Country Status (21)

Country Link
US (1) US20160304553A1 (OSRAM)
EP (1) EP3077047B1 (OSRAM)
JP (2) JP6675310B2 (OSRAM)
KR (1) KR102320191B1 (OSRAM)
CN (2) CN110437298A (OSRAM)
AU (2) AU2014358668B2 (OSRAM)
BR (1) BR112016012465B1 (OSRAM)
CA (1) CA2930232C (OSRAM)
CY (1) CY1121736T1 (OSRAM)
DK (1) DK3077047T3 (OSRAM)
ES (1) ES2732845T3 (OSRAM)
HR (1) HRP20191023T1 (OSRAM)
HU (1) HUE045209T2 (OSRAM)
LT (1) LT3077047T (OSRAM)
PL (1) PL3077047T3 (OSRAM)
PT (1) PT3077047T (OSRAM)
RS (1) RS59067B1 (OSRAM)
SI (1) SI3077047T1 (OSRAM)
SM (1) SMT201900363T1 (OSRAM)
TR (1) TR201909447T4 (OSRAM)
WO (1) WO2015083164A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL227890A0 (en) * 2013-08-08 2014-01-30 Galderm Therapeutics Ltd Antiaging compounds containing bile acid and fatty acid conjugates
TR201909447T4 (tr) * 2013-12-04 2019-07-22 Galmed Res & Development Ltd Aramkol tuzları.
US10849911B2 (en) 2015-06-10 2020-12-01 Galmed Research And Development Ltd. Low dose compositions of Aramachol salts
WO2017008902A1 (de) * 2015-07-12 2017-01-19 Cfso Gmbh Cholecalciferolsulfat-salze und deren verwendung zur behandlung von vitamin d3-mangel
WO2017017677A1 (en) * 2015-07-27 2017-02-02 Galmed Research And Development Ltd. Combination treatment for liver disease
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
FR3050112B1 (fr) 2016-04-15 2020-09-04 Soc Civ Immobiliere Gecinq Utilisation de l'acide fenofibrique dans le traitement des maladies hepatiques
KR102399254B1 (ko) * 2016-09-28 2022-05-17 아이거 바이오파마슈티컬스 인코포레이티드 비-알코올성 지방간염의 치료를 위한 방법 및 약제학적 조성물
US20190275061A1 (en) * 2016-11-10 2019-09-12 Galmed Research And Development Ltd Inhibition of fibrosis in non alcohol fatty liver disease patients
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
US11136347B2 (en) 2017-06-07 2021-10-05 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof
WO2019055280A1 (en) 2017-09-13 2019-03-21 Emmyon, Inc. DIETHANOLAMINE SALTS AND URSOLIC ACID MORPHOLIN
US20190183832A1 (en) * 2017-12-20 2019-06-20 Michael Guarnieri Nutritional bolus for animals
JP6612004B1 (ja) * 2018-07-31 2019-11-27 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026471A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP2025529972A (ja) * 2022-09-02 2025-09-09 レックスファームテック カンパニー リミテッド 新規ベンフォチアミンコリン塩
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2252863A (en) * 1941-02-03 1941-08-19 Searle & Co Quaternary ammonium salts
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
AU781524B2 (en) * 1999-10-13 2005-05-26 Johns Hopkins University School Of Medicine, The Regulators of the hedgehog pathway, compositions and uses related thereto
US8975246B2 (en) * 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
WO2005105091A1 (en) * 2004-04-28 2005-11-10 Merck & Co., Inc. Fluorinated 4-azasteroids as androgen receptor modulators
ITMI20061735A1 (it) * 2006-09-12 2008-03-13 Dipharma Spa Procedimento per la preparazione di acidi colanici
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
EP2391370B1 (en) * 2009-02-02 2015-06-03 Galmed Research and Development Ltd. Methods and compositions for treating alzheimer's disease
WO2011074607A1 (ja) * 2009-12-15 2011-06-23 明治製菓株式会社 トリテルペン誘導体およびc型慢性肝炎の予防または治療のための薬剤
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
MX2012008801A (es) * 2010-01-28 2012-08-17 Merck Sharp & Dohme Composiciones farmaceuticas para el tratamiento de dolor y otras indicaciones.
PT2531501E (pt) * 2010-02-03 2014-02-17 Takeda Pharmaceutical Inibidores da cinase de regulação do sinal de apoptose 1
ES2674174T3 (es) * 2010-12-07 2018-06-27 Bristol-Myers Squibb Company Antagonista de LPA1 policíclico y usos del mismo
TR201909447T4 (tr) * 2013-12-04 2019-07-22 Galmed Res & Development Ltd Aramkol tuzları.

Similar Documents

Publication Publication Date Title
JP2016539131A5 (OSRAM)
HRP20191023T1 (hr) Soli aramchola
JP2014501282A5 (OSRAM)
JP2020519654A5 (OSRAM)
JP2012521994A5 (OSRAM)
JP2013516473A5 (OSRAM)
JP2013541592A5 (OSRAM)
RU2577334C2 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА МОНОГИДРАТА ГИДРОХЛОРИДА (R)-7-ХЛОР-N-(ХИНУКЛИДИН-3-ИЛ)БЕНЗО[b]ТИОФЕН-2-КАРБОКСАМИДА
CN108794481A (zh) 化合物的多晶型、其制备方法和用途
JP2017533895A5 (OSRAM)
TWI721947B (zh) 抗病毒化合物的固態形式
JP2013520501A (ja) チロシンキナーゼのトリメトキシフェニルインヒビター
JP2018507886A5 (OSRAM)
JP2020518571A5 (OSRAM)
JP2010519300A5 (OSRAM)
JP2023083528A5 (OSRAM)
JP2023103328A (ja) ビランテロールトリフェニル酢酸塩の新規な結晶形態及びこれらの調製プロセス
CN102149671A (zh) 甲磺酸雷沙吉兰的多晶形式
JP2017519015A5 (OSRAM)
CN101595099B (zh) 晶体盐酸度洛西汀
JP2012509281A5 (OSRAM)
JP6166721B2 (ja) 4−tert−ブチル−N−[4−クロロ−2−(1−オキシ−ピリジン−4−カルボニル)−フェニル]−ベンゼンスルホンアミドのナトリウム塩の多形
JP2017132781A5 (OSRAM)
JP2018516946A5 (OSRAM)
TW201217346A (en) Process for preparing the crystalline form II of febuxostat